Suchergebnisse - "Mertens, Daniel"

PubPharm (6)

1

Prognostic and predictive role of gene mutations in chronic lymphocytic leukemia : results from the pivotal phase III study COMPLEMENT1

enthalten in: Haematologica | 2020

von Tausch, E. | Beck, P. | Schlenk, R. | +18

CommentIn: Haematologica. 2020 Jun 05;105(10):2352-2355. - PMID 33054074

2

Genomic alterations in high-risk chronic lymphocytic leukemia frequently affect cell cycle key regulators and NOTCH1-regulated transcription

enthalten in: Haematologica | 2020

von Edelmann, J. | Holzmann, K. | Tausch, E. | +24

CommentIn: Haematologica. 2020 May;105(5):1180-1182. - PMID 32358080

3

Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia

enthalten in: Leukemia | 2019

von Jebaraj, B. | Tausch, E. | Landau, D. | +20

4

Gene mutations and treatment outcome in chronic lymphocytic leukemia : results from the CLL8 trial

enthalten in: Blood | 2014

von Stilgenbauer, S. | Schnaiter, A. | Paschka, P. | +29

CommentIn: Blood. 2014 May 22;123(21):3212-4. - PMID 24855188

5

NOTCH1, SF3B1, and TP53 mutations in fludarabine-refractory CLL patients treated with alemtuzumab : results from the CLL2H trial of the GCLLSG

enthalten in: Blood | 2013

von Schnaiter, A. | Paschka, P. | Rossi, M. | +13

6

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL) : dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

enthalten in: Blood | 2009

von Zenz, T. | Häbe, S. | Denzel, T. | +10

1
[1]